Advertisement
New Zealand markets close in 1 hour 51 minutes
  • NZX 50

    11,835.57
    -110.86 (-0.93%)
     
  • NZD/USD

    0.5963
    +0.0013 (+0.22%)
     
  • NZD/EUR

    0.5558
    +0.0018 (+0.32%)
     
  • ALL ORDS

    7,842.60
    -94.90 (-1.20%)
     
  • ASX 200

    7,581.00
    -102.00 (-1.33%)
     
  • OIL

    83.80
    +0.23 (+0.28%)
     
  • GOLD

    2,346.00
    +3.50 (+0.15%)
     
  • NASDAQ

    17,430.50
    -96.30 (-0.55%)
     
  • FTSE

    8,078.86
    +38.48 (+0.48%)
     
  • Dow Jones

    38,085.80
    -375.12 (-0.98%)
     
  • DAX

    17,917.28
    -171.42 (-0.95%)
     
  • Hang Seng

    17,570.05
    +285.51 (+1.65%)
     
  • NIKKEI 225

    37,780.35
    +151.87 (+0.40%)
     
  • NZD/JPY

    92.7360
    +0.2400 (+0.26%)
     

Cancer drug key to $21bln pharma deal

AbbVie is to buy Pharmacyclics Inc for about $21 billion. As Hayley Platt reports it continues a growing M&A trend in the sector and will give the drugmaker access to what is expected to be one of the world's top-selling cancer drugs.